Vaccine Adjuvant
AssigneeWisconsin Alumni Research Foundation
InventorsBruce Steven Klein, Huafeng Wang, Marcel Wuethrich, Tristan Theodore Brandhorst
Life of this patent
Estimating the term…
Abstract
A Dectin-2 ligand vaccine adjuvant and a method of making and using the Dectin-2 ligand vaccine adjuvant in a vaccine to immunize a patient are disclosed. Also discloses is a vaccine composition comprising a Bl-Eng2 antigen and methods of using the vaccine composition to immunize a subject against a fungal infection.
Claims24
A vaccine suitable to immunize a patient comprising an adjuvant, wherein the adjuvant is a Dectin-2 ligand.
(canceled)
(canceled)
A method of preparing a vaccine comprising the steps of,
- (a) preparing a pharmaceutically acceptable vaccine stabilizer;
- and
- (b) introducing to the vaccine stabilizer a suitable antigen and an adjuvant, wherein the adjuvant is a Dectin-2 ligand.
(canceled)
A vaccine composition comprising B1-Eng2 and a pharmaceutically acceptable carrier.
(canceled)
Dependencies are inferred from the claim text.